Astellas Pharma of Japan has agreed to purchase IVERIC Bio for $5.9 billion.
Japan's Astellas Pharma said on Monday it agreed to buy U.S.-based drugmaker…
Search
Have an existing account?
Sign In
Japan's Astellas Pharma said on Monday it agreed to buy U.S.-based drugmaker…
